speb/financial-data huggingface dataset:
HEMO.L balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 636269.00
HEMO.L cash_flow (annual, 2025-12-31) — Capital Expenditure: -3921.00
HEMO.L balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2004246.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2004246.00
HEMO.L balance_sheet (annual, 2025-12-31) — Capital Stock: 60412.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Capital Stock: 60412.00
HEMO.L balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1586430.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1586430.00
HEMO.L balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1586430.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1586430.00
HEMO.L cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 208415.00
HEMO.L cash_flow (annual, 2025-12-31) — Change In Payable: 429486.00
HEMO.L cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 325154.00
HEMO.L cash_flow (annual, 2025-12-31) — Change In Receivables: -5457.00
HEMO.L cash_flow (annual, 2025-12-31) — Change In Working Capital: 957598.00
HEMO.L cash_flow (annual, 2025-12-31) — Changes In Cash: 1435039.00
HEMO.L balance_sheet (annual, 2025-12-31) — Common Stock: 60412.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Common Stock: 60412.00
HEMO.L balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1195391.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1195391.00
HEMO.L cash_flow (annual, 2025-12-31) — Common Stock Issuance: 5522403.00
HEMO.L income_statement (annual, 2025-12-31) — Cost Of Revenue: 929890.00
HEMO.L balance_sheet (annual, 2025-12-31) — Current Assets: 2034519.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Current Assets: 2034519.00
HEMO.L balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 442416.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 442416.00
HEMO.L balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 442416.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 442416.00
HEMO.L balance_sheet (annual, 2025-12-31) — Current Liabilities: 1469644.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1469644.00
HEMO.L cash_flow (annual, 2025-12-31) — Depreciation: 588753.00
HEMO.L cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 588753.00
HEMO.L income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 588753.00
HEMO.L income_statement (annual, 2025-12-31) — Depreciation Income Statement: 588753.00
HEMO.L income_statement (annual, 2025-12-31) — Diluted Average Shares: 4442691.00
HEMO.L income_statement (annual, 2025-12-31) — Diluted EPS: -1.71
HEMO.L income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -9760364.00
HEMO.L income_statement (annual, 2025-12-31) — EBIT: -9537707.00
HEMO.L income_statement (annual, 2025-12-31) — EBITDA: -8948954.00
HEMO.L cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -7874.00
HEMO.L cash_flow (annual, 2025-12-31) — End Cash Position: 1586430.00
HEMO.L cash_flow (annual, 2025-12-31) — Financing Cash Flow: 4889828.00
HEMO.L cash_flow (annual, 2025-12-31) — Free Cash Flow: -3451913.00
HEMO.L cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 2293128.00
HEMO.L cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 22156.00
HEMO.L cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -17555.00
HEMO.L income_statement (annual, 2025-12-31) — General And Administrative Expense: 1698342.00
HEMO.L balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 182025.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 182025.00
HEMO.L balance_sheet (annual, 2025-12-31) — Gross PPE: 2602020.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2602020.00
HEMO.L income_statement (annual, 2025-12-31) — Gross Profit: -929890.00
HEMO.L income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 267969.00
HEMO.L income_statement (annual, 2025-12-31) — Interest Expense: 229546.00
HEMO.L income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 229546.00
HEMO.L income_statement (annual, 2025-12-31) — Interest Income: 1131.00
HEMO.L income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1131.00
HEMO.L cash_flow (annual, 2025-12-31) — Interest Received Cfi: 1131.00
HEMO.L balance_sheet (annual, 2025-12-31) — Invested Capital: 1195391.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1195391.00
HEMO.L cash_flow (annual, 2025-12-31) — Investing Cash Flow: -6797.00
HEMO.L cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 5522403.00
HEMO.L balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1561830.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1561830.00
HEMO.L balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1561830.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1561830.00
HEMO.L balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 41156.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 41156.00
HEMO.L balance_sheet (annual, 2025-12-31) — Minority Interest: -50909.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Minority Interest: -50909.00
HEMO.L income_statement (annual, 2025-12-31) — Minority Interests: 6889.00
HEMO.L cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 5522403.00
HEMO.L cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 1915645.00
HEMO.L income_statement (annual, 2025-12-31) — Net Income: -9760364.00
HEMO.L income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9760364.00
HEMO.L income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -9767253.00
HEMO.L income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9760364.00
HEMO.L income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9760364.00
HEMO.L cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -9767253.00
HEMO.L income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -9767253.00
HEMO.L income_statement (annual, 2025-12-31) — Net Interest Income: -228415.00
HEMO.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -228415.00
HEMO.L cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4007.00
HEMO.L balance_sheet (annual, 2025-12-31) — Net PPE: 1802639.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 1802639.00
HEMO.L cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -3921.00
HEMO.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1013366.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1013366.00
HEMO.L balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 156773.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 156773.00
HEMO.L income_statement (annual, 2025-12-31) — Normalized EBITDA: -6383256.00
HEMO.L income_statement (annual, 2025-12-31) — Normalized Income: -7194666.00
HEMO.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: -3447992.00
HEMO.L income_statement (annual, 2025-12-31) — Operating Income: -4660889.00
HEMO.L income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
HEMO.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 6041255.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 6041255.00
HEMO.L balance_sheet (annual, 2025-12-31) — Other Equity Interest: 13983115.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 13983115.00
HEMO.L balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 182025.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 182025.00
HEMO.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: 228415.00
HEMO.L income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 7118.00
HEMO.L balance_sheet (annual, 2025-12-31) — Other Properties: 1924595.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Other Properties: 1924595.00
HEMO.L income_statement (annual, 2025-12-31) — Other Special Charges: 4601.00
HEMO.L income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HEMO.L balance_sheet (annual, 2025-12-31) — Payables: 965148.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Payables: 965148.00
HEMO.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 435249.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 435249.00
HEMO.L income_statement (annual, 2025-12-31) — Pretax Income: -9767253.00
HEMO.L balance_sheet (annual, 2025-12-31) — Properties: 0.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HEMO.L cash_flow (annual, 2025-12-31) — Purchase Of PPE: -3921.00
HEMO.L income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 929890.00
HEMO.L income_statement (annual, 2025-12-31) — Reconciled Depreciation: 588753.00
HEMO.L balance_sheet (annual, 2025-12-31) — Retained Earnings: -38750687.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -38750687.00
HEMO.L income_statement (annual, 2025-12-31) — Selling General And Administration: 1698342.00
HEMO.L balance_sheet (annual, 2025-12-31) — Share Issued: 6041255.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 6041255.00
HEMO.L income_statement (annual, 2025-12-31) — Special Income Charges: -272570.00
HEMO.L cash_flow (annual, 2025-12-31) — Stock Based Compensation: 63152.00
HEMO.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1195391.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1195391.00
HEMO.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1013366.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1013366.00
HEMO.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HEMO.L income_statement (annual, 2025-12-31) — Tax Provision: 0.00
HEMO.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
HEMO.L balance_sheet (annual, 2025-12-31) — Taxes Receivable: 4064.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 4064.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Assets: 4175956.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 4175956.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 1195391.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1195391.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Debt: 2004246.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 2004246.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1144482.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1144482.00
HEMO.L income_statement (annual, 2025-12-31) — Total Expenses: 4660889.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3031474.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3031474.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 2141437.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2141437.00
HEMO.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1561830.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1561830.00
HEMO.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -6980258.00
HEMO.L income_statement (annual, 2025-12-31) — Total Unusual Items: -2565698.00
HEMO.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2565698.00
HEMO.L balance_sheet (annual, 2025-12-31) — Working Capital: 564875.00
HEMO.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 564875.00
HEMP.V income_statement (annual, 2023-09-30) — +Operating Expense: 1564800.00
HEMP.V income_statement (annual, 2023-09-30) — +Total Revenue: 436083.00
HEMP.V balance_sheet (annual, 2023-09-30) — Accounts Payable: 223027.00
HEMP.V balance_sheet (annual, 2023-09-30) — Accounts Receivable: 40086.00
HEMP.V balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -704006.00
HEMP.V balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 487261.00
HEMP.V income_statement (annual, 2023-09-30) — Amortization: 457438.00
HEMP.V cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 63315.00
HEMP.V cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 63315.00
HEMP.V income_statement (annual, 2023-09-30) — Amortization Of Intangibles Income Statement: 457438.00
HEMP.V cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Basic Average Shares: 44674622.00
HEMP.V income_statement (annual, 2023-09-30) — Basic EPS: -0.04
HEMP.V cash_flow (annual, 2023-09-30) — Beginning Cash Position: 129266.00
HEMP.V cash_flow (annual, 2023-09-30) — Capital Expenditure: -115978.00
HEMP.V balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 1128114.00
HEMP.V balance_sheet (annual, 2023-09-30) — Capital Stock: 4489263.00
HEMP.V balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 560681.00
HEMP.V balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 560681.00
HEMP.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: 1831470.00
HEMP.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -115978.00
HEMP.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: -1284077.00
HEMP.V cash_flow (annual, 2023-09-30) — Change In Inventory: -129811.00
HEMP.V cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: 162579.00
HEMP.V cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: -201511.00
HEMP.V cash_flow (annual, 2023-09-30) — Change In Receivables: 567.00
HEMP.V cash_flow (annual, 2023-09-30) — Change In Working Capital: -168176.00
HEMP.V cash_flow (annual, 2023-09-30) — Changes In Account Receivables: 567.00
HEMP.V cash_flow (annual, 2023-09-30) — Changes In Cash: 431415.00
HEMP.V balance_sheet (annual, 2023-09-30) — Common Stock: 4489263.00
HEMP.V balance_sheet (annual, 2023-09-30) — Common Stock Equity: 1676322.00
HEMP.V cash_flow (annual, 2023-09-30) — Common Stock Issuance: 1283006.00
HEMP.V income_statement (annual, 2023-09-30) — Cost Of Revenue: 615488.00
HEMP.V balance_sheet (annual, 2023-09-30) — Current Assets: 1163249.00
HEMP.V balance_sheet (annual, 2023-09-30) — Current Capital Lease Obligation: 143597.00
HEMP.V balance_sheet (annual, 2023-09-30) — Current Debt: 491653.00
HEMP.V balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 635250.00
HEMP.V balance_sheet (annual, 2023-09-30) — Current Liabilities: 858277.00
HEMP.V balance_sheet (annual, 2023-09-30) — Current Notes Payable: 300000.00
HEMP.V cash_flow (annual, 2023-09-30) — Depreciation: 394123.00
HEMP.V cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 457438.00
HEMP.V income_statement (annual, 2023-09-30) — Depreciation Amortization Depletion Income Statement: 457438.00
HEMP.V cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 457438.00
HEMP.V income_statement (annual, 2023-09-30) — Depreciation And Amortization In Income Statement: 457438.00
HEMP.V income_statement (annual, 2023-09-30) — Diluted Average Shares: 44674622.00
HEMP.V income_statement (annual, 2023-09-30) — Diluted EPS: -0.04
HEMP.V income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -1842734.00
HEMP.V balance_sheet (annual, 2023-09-30) — Dueto Related Parties Current: 0.00
HEMP.V income_statement (annual, 2023-09-30) — EBIT: -1751402.00
HEMP.V income_statement (annual, 2023-09-30) — EBITDA: -1293964.00
HEMP.V cash_flow (annual, 2023-09-30) — End Cash Position: 560681.00
HEMP.V cash_flow (annual, 2023-09-30) — Financing Cash Flow: 1831470.00
HEMP.V balance_sheet (annual, 2023-09-30) — Finished Goods: 78217.00
HEMP.V cash_flow (annual, 2023-09-30) — Free Cash Flow: -1400055.00
HEMP.V income_statement (annual, 2023-09-30) — General And Administrative Expense: 1024515.00
HEMP.V balance_sheet (annual, 2023-09-30) — Goodwill: 0.00
HEMP.V balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 397051.00
HEMP.V balance_sheet (annual, 2023-09-30) — Gross PPE: 3785677.00
HEMP.V income_statement (annual, 2023-09-30) — Gross Profit: -179405.00
HEMP.V income_statement (annual, 2023-09-30) — Impairment Of Capital Assets: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Interest Expense: 91332.00
HEMP.V income_statement (annual, 2023-09-30) — Interest Expense Non Operating: 91332.00
HEMP.V balance_sheet (annual, 2023-09-30) — Inventory: 347929.00
HEMP.V balance_sheet (annual, 2023-09-30) — Invested Capital: 3290830.00
HEMP.V cash_flow (annual, 2023-09-30) — Investing Cash Flow: -115978.00
HEMP.V cash_flow (annual, 2023-09-30) — Issuance Of Capital Stock: 1283006.00
HEMP.V cash_flow (annual, 2023-09-30) — Issuance Of Debt: 565000.00
HEMP.V balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 984517.00
HEMP.V balance_sheet (annual, 2023-09-30) — Long Term Debt: 1122855.00
HEMP.V balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 2107372.00
HEMP.V cash_flow (annual, 2023-09-30) — Long Term Debt Issuance: 565000.00
HEMP.V cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -321536.00
HEMP.V balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 123534.00
HEMP.V balance_sheet (annual, 2023-09-30) — Minority Interest: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Minority Interests: 0.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: 0.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: 1283006.00
HEMP.V balance_sheet (annual, 2023-09-30) — Net Debt: 1053827.00
HEMP.V income_statement (annual, 2023-09-30) — Net Income: -1842734.00
HEMP.V income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -1842734.00
HEMP.V income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -1842734.00
HEMP.V income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -1842734.00
HEMP.V income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -1842734.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -1842734.00
HEMP.V income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -1842734.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Intangibles Purchase And Sale: -30000.00
HEMP.V income_statement (annual, 2023-09-30) — Net Interest Income: -98529.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: 543464.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: 243464.00
HEMP.V income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: -98529.00
HEMP.V balance_sheet (annual, 2023-09-30) — Net PPE: 3081671.00
HEMP.V cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -85978.00
HEMP.V cash_flow (annual, 2023-09-30) — Net Short Term Debt Issuance: 300000.00
HEMP.V balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 1279271.00
HEMP.V balance_sheet (annual, 2023-09-30) — Non Current Deferred Liabilities: 0.00
HEMP.V balance_sheet (annual, 2023-09-30) — Non Current Deferred Revenue: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Normalized EBITDA: -1293964.00
HEMP.V income_statement (annual, 2023-09-30) — Normalized Income: -1842734.00
HEMP.V cash_flow (annual, 2023-09-30) — Operating Cash Flow: -1284077.00
HEMP.V income_statement (annual, 2023-09-30) — Operating Income: -1744205.00
HEMP.V income_statement (annual, 2023-09-30) — Operating Revenue: 436083.00
HEMP.V balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 82444176.00
HEMP.V balance_sheet (annual, 2023-09-30) — Other Current Borrowings: 191653.00
HEMP.V balance_sheet (annual, 2023-09-30) — Other Equity Interest: 83928.00
HEMP.V income_statement (annual, 2023-09-30) — Other Gand A: -183737.00
HEMP.V balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 397051.00
HEMP.V cash_flow (annual, 2023-09-30) — Other Non Cash Items: 44875.00
HEMP.V income_statement (annual, 2023-09-30) — Other Operating Expenses: -99977.00
HEMP.V balance_sheet (annual, 2023-09-30) — Other Properties: 3662143.00
HEMP.V balance_sheet (annual, 2023-09-30) — Payables: 223027.00
HEMP.V balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 223027.00
HEMP.V balance_sheet (annual, 2023-09-30) — Prepaid Assets: 214553.00
HEMP.V income_statement (annual, 2023-09-30) — Pretax Income: -1842734.00
HEMP.V cash_flow (annual, 2023-09-30) — Proceeds From Stock Option Exercised: 5000.00
HEMP.V cash_flow (annual, 2023-09-30) — Purchase Of Business: 0.00
HEMP.V cash_flow (annual, 2023-09-30) — Purchase Of Intangibles: -30000.00
HEMP.V cash_flow (annual, 2023-09-30) — Purchase Of PPE: -85978.00
HEMP.V balance_sheet (annual, 2023-09-30) — Raw Materials: 71679.00
HEMP.V balance_sheet (annual, 2023-09-30) — Receivables: 40086.00
HEMP.V income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 615488.00
HEMP.V income_statement (annual, 2023-09-30) — Reconciled Depreciation: 457438.00
HEMP.V cash_flow (annual, 2023-09-30) — Repayment Of Debt: -321536.00
HEMP.V income_statement (annual, 2023-09-30) — Restructuring And Mergern Acquisition: 0.00
HEMP.V balance_sheet (annual, 2023-09-30) — Retained Earnings: -3384130.00
HEMP.V income_statement (annual, 2023-09-30) — Salaries And Wages: 1208252.00
HEMP.V cash_flow (annual, 2023-09-30) — Sale Of Business: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Selling And Marketing Expense: 182824.00
HEMP.V income_statement (annual, 2023-09-30) — Selling General And Administration: 1207339.00
HEMP.V balance_sheet (annual, 2023-09-30) — Share Issued: 82444176.00
HEMP.V income_statement (annual, 2023-09-30) — Special Income Charges: 0.00
HEMP.V cash_flow (annual, 2023-09-30) — Stock Based Compensation: 224520.00
HEMP.V balance_sheet (annual, 2023-09-30) — Stockholders Equity: 1676322.00
HEMP.V balance_sheet (annual, 2023-09-30) — Tangible Book Value: 1279271.00
HEMP.V income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Assets: 4641971.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Capitalization: 2799177.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Debt: 2742622.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 1676322.00
HEMP.V income_statement (annual, 2023-09-30) — Total Expenses: 2180288.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 2965649.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 3478722.00
HEMP.V balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 2107372.00
HEMP.V income_statement (annual, 2023-09-30) — Total Other Finance Cost: 7197.00
HEMP.V income_statement (annual, 2023-09-30) — Total Unusual Items: 0.00
HEMP.V income_statement (annual, 2023-09-30) — Total Unusual Items Excluding Goodwill: 0.00
HEMP.V balance_sheet (annual, 2023-09-30) — Work In Process: 198033.00
HEMP.V balance_sheet (annual, 2023-09-30) — Working Capital: 304972.00
HEMP.V income_statement (annual, 2024-09-30) — +Operating Expense: 497785.00
HEMP.V income_statement (annual, 2024-09-30) — +Total Revenue: 11751.00
HEMP.V balance_sheet (annual, 2024-09-30) — Accounts Payable: 142910.00
HEMP.V balance_sheet (annual, 2024-09-30) — Accounts Receivable: 123144.00
HEMP.V balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -1066613.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -1066613.00
HEMP.V balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 980575.00
HEMP.V income_statement (annual, 2024-09-30) — Amortization: 430797.00
HEMP.V income_statement (quarterly, 2024-09-30) — Amortization: 379655.00
HEMP.V cash_flow (annual, 2024-09-30) — Amortization Cash Flow: 68189.00
HEMP.V cash_flow (annual, 2024-09-30) — Amortization Of Intangibles: 68189.00
HEMP.V income_statement (annual, 2024-09-30) — Amortization Of Intangibles Income Statement: 430797.00
HEMP.V income_statement (quarterly, 2024-09-30) — Amortization Of Intangibles Income Statement: 379655.00
HEMP.V cash_flow (annual, 2024-09-30) — Asset Impairment Charge: 2044062.00
HEMP.V balance_sheet (annual, 2024-09-30) — Assets Held For Sale Current: 0.00
HEMP.V income_statement (annual, 2024-09-30) — Basic Average Shares: 71192124.00
HEMP.V income_statement (annual, 2024-09-30) — Basic EPS: -0.09
HEMP.V cash_flow (annual, 2024-09-30) — Beginning Cash Position: 560681.00
HEMP.V cash_flow (annual, 2024-09-30) — Capital Expenditure: -657595.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -250395.00
HEMP.V balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 984517.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 984517.00
HEMP.V balance_sheet (annual, 2024-09-30) — Capital Stock: 12089456.00
HEMP.V balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 726514.00
HEMP.V balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 726514.00
HEMP.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: 480035.00
HEMP.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: 1755609.00
HEMP.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: -2069812.00
HEMP.V cash_flow (annual, 2024-09-30) — Change In Inventory: -53547.00
HEMP.V cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: -80118.00
HEMP.V cash_flow (annual, 2024-09-30) — Change In Prepaid Assets: 72230.00
HEMP.V cash_flow (annual, 2024-09-30) — Change In Receivables: -83058.00
HEMP.V cash_flow (annual, 2024-09-30) — Change In Working Capital: -144493.00
HEMP.V cash_flow (annual, 2024-09-30) — Changes In Account Receivables: -83058.00
HEMP.V cash_flow (annual, 2024-09-30) — Changes In Cash: 165833.00
HEMP.V balance_sheet (annual, 2024-09-30) — Common Stock: 12089456.00
HEMP.V balance_sheet (annual, 2024-09-30) — Common Stock Equity: 3243424.00
HEMP.V cash_flow (annual, 2024-09-30) — Common Stock Issuance: 1001460.00
HEMP.V income_statement (annual, 2024-09-30) — Cost Of Revenue: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Current Assets: 1393457.00
HEMP.V balance_sheet (annual, 2024-09-30) — Current Capital Lease Obligation: 150276.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 150276.00
HEMP.V balance_sheet (annual, 2024-09-30) — Current Debt: 197473.00
HEMP.V balance_sheet (annual, 2024-09-30) — Current Debt And Capital Lease Obligation: 347749.00
HEMP.V balance_sheet (annual, 2024-09-30) — Current Liabilities: 681385.00
HEMP.V balance_sheet (annual, 2024-09-30) — Current Notes Payable: 0.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Current Notes Payable: 0.00
HEMP.V cash_flow (annual, 2024-09-30) — Depreciation: 362607.00
HEMP.V cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 430796.00
HEMP.V income_statement (annual, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 430797.00
HEMP.V income_statement (quarterly, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 107699.00
HEMP.V cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 430796.00
HEMP.V income_statement (annual, 2024-09-30) — Depreciation And Amortization In Income Statement: 430797.00
HEMP.V income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 107699.00
HEMP.V income_statement (annual, 2024-09-30) — Diluted Average Shares: 71192124.00
HEMP.V income_statement (annual, 2024-09-30) — Diluted EPS: -0.09
HEMP.V income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: -6442477.00
HEMP.V balance_sheet (annual, 2024-09-30) — Dueto Related Parties Current: 190726.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 190726.00
HEMP.V income_statement (annual, 2024-09-30) — EBIT: -4284818.00
HEMP.V income_statement (annual, 2024-09-30) — EBITDA: -3854022.00
HEMP.V cash_flow (annual, 2024-09-30) — End Cash Position: 726514.00
HEMP.V cash_flow (annual, 2024-09-30) — Financing Cash Flow: 480035.00
HEMP.V balance_sheet (annual, 2024-09-30) — Finished Goods: 176212.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Finished Goods: 176212.00
HEMP.V cash_flow (annual, 2024-09-30) — Free Cash Flow: -2727406.00
HEMP.V income_statement (annual, 2024-09-30) — General And Administrative Expense: 413546.00
HEMP.V balance_sheet (annual, 2024-09-30) — Goodwill: 90000.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Goodwill: 90000.00
HEMP.V balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 488862.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 488862.00
HEMP.V balance_sheet (annual, 2024-09-30) — Gross PPE: 4373272.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Gross PPE: 4373272.00
HEMP.V income_statement (annual, 2024-09-30) — Gross Profit: 11751.00
HEMP.V income_statement (annual, 2024-09-30) — Impairment Of Capital Assets: 2044062.00
HEMP.V income_statement (annual, 2024-09-30) — Interest Expense: 0.00
HEMP.V income_statement (annual, 2024-09-30) — Interest Expense Non Operating: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Inventory: 401476.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Inventory: 401476.00
HEMP.V balance_sheet (annual, 2024-09-30) — Invested Capital: 3921530.00
HEMP.V cash_flow (annual, 2024-09-30) — Investing Cash Flow: 1755609.00
HEMP.V cash_flow (annual, 2024-09-30) — Issuance Of Capital Stock: 1001460.00
HEMP.V cash_flow (annual, 2024-09-30) — Issuance Of Debt: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 834241.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 834241.00
HEMP.V balance_sheet (annual, 2024-09-30) — Long Term Debt: 480633.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 480633.00
HEMP.V balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1314874.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1314874.00
HEMP.V cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 0.00
HEMP.V cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -716027.00
HEMP.V balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 711129.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 711129.00
HEMP.V balance_sheet (annual, 2024-09-30) — Minority Interest: -54581.00
HEMP.V income_statement (annual, 2024-09-30) — Minority Interests: 54581.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Business Purchase And Sale: 2413204.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 2476326.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: 1001460.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income: -6442477.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income Common Stockholders: -6442477.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income Continuous Operations: -4284818.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income Discontinuous Operations: -2212240.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -6442477.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -4230237.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: -6497058.00
HEMP.V income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: -6497058.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Intangibles Purchase And Sale: -70000.00
HEMP.V income_statement (annual, 2024-09-30) — Net Interest Income: -1409.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -716027.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -716027.00
HEMP.V income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: -1409.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Other Financing Charges: 194602.00
HEMP.V balance_sheet (annual, 2024-09-30) — Net PPE: 3306659.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Net PPE: 3306659.00
HEMP.V cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -587595.00
HEMP.V cash_flow (annual, 2024-09-30) — Net Short Term Debt Issuance: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 2754562.00
HEMP.V balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 3876.00
HEMP.V balance_sheet (annual, 2024-09-30) — Non Current Deferred Revenue: 3876.00
HEMP.V income_statement (annual, 2024-09-30) — Normalized EBITDA: -5971.00
HEMP.V income_statement (annual, 2024-09-30) — Normalized Income: -382186.00
HEMP.V cash_flow (annual, 2024-09-30) — Operating Cash Flow: -2069811.00
HEMP.V income_statement (annual, 2024-09-30) — Operating Income: -486034.00
HEMP.V income_statement (annual, 2024-09-30) — Operating Revenue: 11751.00
HEMP.V balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 94944176.00
HEMP.V cash_flow (annual, 2024-09-30) — Other Cash Adjustment Outside Changein Cash: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Other Current Borrowings: 197473.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 197473.00
HEMP.V income_statement (annual, 2024-09-30) — Other Gand A: 253122.00
HEMP.V income_statement (annual, 2024-09-30) — Other Income Expense: -3797375.00
HEMP.V income_statement (quarterly, 2024-09-30) — Other Income Expense: -3822441.00
HEMP.V balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 398862.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 398862.00
HEMP.V cash_flow (annual, 2024-09-30) — Other Non Cash Items: 1954821.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 1776257.00
HEMP.V income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: 50676.00
HEMP.V income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 25610.00
HEMP.V income_statement (annual, 2024-09-30) — Other Operating Expenses: -13634.00
HEMP.V income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Other Properties: 3662143.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Other Properties: 3662143.00
HEMP.V balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 0.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Payables: 333636.00
HEMP.V balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 333636.00
HEMP.V balance_sheet (annual, 2024-09-30) — Prepaid Assets: 142323.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 142323.00
HEMP.V income_statement (annual, 2024-09-30) — Pretax Income: -4284818.00
HEMP.V cash_flow (annual, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
HEMP.V cash_flow (annual, 2024-09-30) — Purchase Of Business: -134062.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 45208.00
HEMP.V cash_flow (annual, 2024-09-30) — Purchase Of Intangibles: -70000.00
HEMP.V cash_flow (annual, 2024-09-30) — Purchase Of PPE: -587595.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -250395.00
HEMP.V balance_sheet (annual, 2024-09-30) — Raw Materials: 89642.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Raw Materials: 89642.00
HEMP.V balance_sheet (annual, 2024-09-30) — Receivables: 123144.00
HEMP.V income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 0.00
HEMP.V income_statement (annual, 2024-09-30) — Reconciled Depreciation: 430796.00
HEMP.V cash_flow (annual, 2024-09-30) — Repayment Of Debt: -716027.00
HEMP.V income_statement (annual, 2024-09-30) — Restructuring And Mergern Acquisition: 1803989.00
HEMP.V balance_sheet (annual, 2024-09-30) — Retained Earnings: -9826607.00
HEMP.V income_statement (annual, 2024-09-30) — Salaries And Wages: 160424.00
HEMP.V cash_flow (annual, 2024-09-30) — Sale Of Business: 2547266.00
HEMP.V cash_flow (quarterly, 2024-09-30) — Sale Of Business: 2431118.00
HEMP.V income_statement (annual, 2024-09-30) — Selling And Marketing Expense: 84239.00
HEMP.V income_statement (annual, 2024-09-30) — Selling General And Administration: 497785.00
HEMP.V balance_sheet (annual, 2024-09-30) — Share Issued: 94944176.00
HEMP.V cash_flow (annual, 2024-09-30) — Short Term Debt Issuance: 0.00
HEMP.V income_statement (annual, 2024-09-30) — Special Income Charges: -3848051.00
HEMP.V cash_flow (annual, 2024-09-30) — Stock Based Compensation: 142061.00
HEMP.V balance_sheet (annual, 2024-09-30) — Stockholders Equity: 3243424.00
HEMP.V balance_sheet (annual, 2024-09-30) — Tangible Book Value: 2754562.00
HEMP.V income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
HEMP.V income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Assets: 5188978.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Capitalization: 3724057.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Debt: 1662623.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 3188843.00
HEMP.V income_statement (annual, 2024-09-30) — Total Expenses: 497785.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 2000135.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 3795521.00
HEMP.V balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1318750.00
HEMP.V income_statement (annual, 2024-09-30) — Total Other Finance Cost: 1409.00
HEMP.V income_statement (annual, 2024-09-30) — Total Unusual Items: -3848051.00
HEMP.V income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: -3848051.00
HEMP.V balance_sheet (annual, 2024-09-30) — Work In Process: 135622.00
HEMP.V balance_sheet (quarterly, 2024-09-30) — Work In Process: 135622.00
HEMP.V balance_sheet (annual, 2024-09-30) — Working Capital: 712072.00
HEMP.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 295114.00
HEMP.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 133.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 213223.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 54756.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1151380.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 1015040.00
HEMP.V income_statement (quarterly, 2024-12-31) — Amortization: 17047.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 101814.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 101814.00
HEMP.V income_statement (quarterly, 2024-12-31) — Amortization Of Intangibles Income Statement: 17047.00
HEMP.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 91396524.00
HEMP.V income_statement (quarterly, 2024-12-31) — Basic EPS: 0.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 726514.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -105744.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 947585.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 12089456.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 182768.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 182768.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -46535.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -105744.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -391467.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Change In Inventory: -3569.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 70313.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -8.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: 68388.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 135124.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 68388.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: -543746.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 12089456.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 2790083.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
HEMP.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 0.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 784900.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 151993.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 131958.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 283951.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 497174.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 101814.00
HEMP.V income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 101814.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 101814.00
HEMP.V income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 101814.00
HEMP.V income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 84767.00
HEMP.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 91396524.00
HEMP.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.00
HEMP.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -61671.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 0.00
HEMP.V income_statement (quarterly, 2024-12-31) — EBIT: -67560.00
HEMP.V income_statement (quarterly, 2024-12-31) — EBITDA: 34254.00
HEMP.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 182768.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -46535.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Finished Goods: 156432.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -497211.00
HEMP.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 252547.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Goodwill: 180000.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 561815.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 4389016.00
HEMP.V income_statement (quarterly, 2024-12-31) — Gross Profit: 133.00
HEMP.V income_statement (quarterly, 2024-12-31) — Interest Expense: 167.00
HEMP.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 167.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Inventory: 405045.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 3419628.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -105744.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 795592.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 497587.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1293179.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -85454.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 726873.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 446777.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Income: -61671.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -61671.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -67727.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -61671.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -61671.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -432281.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -61671.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -90000.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -307.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -85454.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -85454.00
HEMP.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -307.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 38919.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 3237636.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -15744.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 2228268.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 3915.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 3915.00
HEMP.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -196335.00
HEMP.V income_statement (quarterly, 2024-12-31) — Normalized Income: -292260.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -391467.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -230589.00
HEMP.V income_statement (quarterly, 2024-12-31) — Operating Income: -294981.00
HEMP.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 133.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 94944176.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 131958.00
HEMP.V income_statement (quarterly, 2024-12-31) — Other Gand A: 177597.00
HEMP.V income_statement (quarterly, 2024-12-31) — Other Income Expense: 227561.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 381815.00
HEMP.V income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -3028.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 3662143.00
HEMP.V income_statement (quarterly, 2024-12-31) — Other Special Charges: -230589.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Payables: 213223.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 213223.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 142331.00
HEMP.V income_statement (quarterly, 2024-12-31) — Pretax Income: -67727.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -90000.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -15744.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Raw Materials: 87436.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Receivables: 54756.00
HEMP.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
HEMP.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 101814.00
HEMP.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -85454.00
HEMP.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -10314413.00
HEMP.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 74950.00
HEMP.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 42567.00